⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NAMS News
NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
NAMS
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
NAMSW
NAMS
Form 8-K
sec.gov
NAMS
NAMSW
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
globenewswire.com
NAMSW
NAMS
NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
NAMSW
NAMS
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
NAMSW
NAMS
NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit
globenewswire.com
NAMSW
NAMS
NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
globenewswire.com
NAMS
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
NAMS
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
NAMS